Acute Hepatic Porphyria Should Be Included in the Diagnostic Work-Up of Patients with Resistant Hypertension or Suspected Secondary Hypertension
Medical Sciences · 06.02.2025 · 13 (1) · 14
DOI: 10.3390/medsci13010014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 06.02.2025. Verfasst von Paulo de Lima Serrano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Porphyria Unit, Division of Neuromuscular Diseases, Federal University of São Paulo (UNIFESP), São Paulo 04039-060, SP, Brazil. Hauptthemen laut MEDLINE: Hypertension, Porphyrias, Hepatic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Secondary hypertension and resistant hypertension may result from potentially treatable acquired or hereditary diseases. Inherited Metabolic Disorders are not routinely included in the differential diagnosis of these contexts associated with hypertension, despite the key importance of diagnosis for several of them which enable the early treatment of them. We aim to discuss the current evidence that indicates that a significant portion of cases of unknown resistant hypertension or suspected secondary hypertension may result from unrecognized Acute Hepatic Porphyria (AHP). Diagnostic work-up for AHP is not routinely performed during the evaluation of patients with resistant or refractory hypertension nor in the investigation of secondary hypertension. AHP may present both with neurological and systemic involvement, and hypertension may be observed as part of acute dysautonomia during acute neurovisceral attacks and as a chronic complication during disease course. As AHP represent a potentially treatable group of metabolic disorders, clinicians should consider the inclusion of this group in the diagnostic evaluation of patients with secondary or resistant hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Porphyria Unit, Division of Neuromuscular Diseases, Federal University of São Paulo (UNIFESP), São Paulo 04039-060, SP, Brazil.
ORCID-Profile: Bruno de Mattos Lombardi Badia, Wladimir Bocca Vieira de Rezende Pinto, Acary Souza Bulle Oliveira, Paulo Sgobbi
Zitieren
APA
de Lima Serrano, P., de Mattos Lombardi Badia, B., Barile, J. P., Mendes, P. M., Cavalheiro, R. B. R., Peixoto, K. O., Farias, I. B., Machado, R. I. L., Seneor, D. D., de Rezende Pinto, W. B. V., Oliveira, A. S. B., & Sgobbi, P. (2025). Acute Hepatic Porphyria Should Be Included in the Diagnostic Work-Up of Patients with Resistant Hypertension or Suspected Secondary Hypertension. Medical Sciences, 13(1), 14. https://doi.org/10.3390/medsci13010014
Vancouver
de Lima Serrano P, de Mattos Lombardi Badia B, Barile JP, Mendes PM, Cavalheiro RBR, Peixoto KO, et al. Acute Hepatic Porphyria Should Be Included in the Diagnostic Work-Up of Patients with Resistant Hypertension or Suspected Secondary Hypertension. Medical Sciences. 2025;13(1):14. doi:10.3390/medsci13010014
BibTeX
@article{deLimaSerrano2025,
author = {de Lima Serrano, Paulo and de Mattos Lombardi Badia, Bruno and Barile, João Paulo and Mendes, Patrícia Marques and Cavalheiro, Renan Brandão Rambaldi and Peixoto, Kaliny Oliveira and Farias, Igor Braga and Machado, Roberta Ismael Lacerda and Seneor, Daniel Delgado and de Rezende Pinto, Wladimir Bocca Vieira and Oliveira, Acary Souza Bulle and Sgobbi, Paulo},
title = {Acute Hepatic Porphyria Should Be Included in the Diagnostic Work-Up of Patients with Resistant Hypertension or Suspected Secondary Hypertension},
journal = {Medical Sciences},
year = {2025},
volume = {13},
number = {1},
pages = {14},
doi = {10.3390/medsci13010014}
}
EUVIMED